GURUFOCUS.COM » STOCK LIST » Real Estate » REITs » BioMed Realty Trust Inc (NYSE:BMR) » Definitions » Piotroski F-Score

BioMed Realty Trust (BioMed Realty Trust) Piotroski F-Score : 0 (As of Apr. 29, 2024)


View and export this data going back to . Start your Free Trial

What is BioMed Realty Trust Piotroski F-Score?

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

BioMed Realty Trust has an F-score of 6 indicating the company's financial situation is typical for a stable company.

The historical rank and industry rank for BioMed Realty Trust's Piotroski F-Score or its related term are showing as below:


BioMed Realty Trust Piotroski F-Score Historical Data

The historical data trend for BioMed Realty Trust's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioMed Realty Trust Piotroski F-Score Chart

BioMed Realty Trust Annual Data
Trend Dec05 Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14
Piotroski F-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.00 4.00 5.00 6.00 5.00

BioMed Realty Trust Quarterly Data
Dec10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.00 5.00 5.00 6.00 6.00

How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Sep15) TTM:Last Year (Sep14) TTM:
Net Income was 140.349 + 17.345 + 23.578 + 28.203 = $209.5 Mil.
Cash Flow from Operations was 73.987 + 76.663 + 55.485 + 74.395 = $280.5 Mil.
Revenue was 165.656 + 178.01 + 157.974 + 174.348 = $676.0 Mil.
Gross Profit was 112.212 + 119.363 + 102.704 + 112.279 = $446.6 Mil.
Average Total Assets from the begining of this year (Sep14)
to the end of this year (Sep15) was
(6238.312 + 6170.886 + 6308.418 + 6338.209 + 6460.696) / 5 = $6303.3042 Mil.
Total Assets at the begining of this year (Sep14) was $6,238.3 Mil.
Long-Term Debt & Capital Lease Obligation was $2,532.2 Mil.
Total Current Assets was $710.1 Mil.
Total Current Liabilities was $882.4 Mil.
Net Income was 10.279 + 18.833 + 18.636 + 15.96 = $63.7 Mil.

Revenue was 157.993 + 168.876 + 171.161 + 168.916 = $666.9 Mil.
Gross Profit was 108.102 + 116.353 + 117.525 + 114.017 = $456.0 Mil.
Average Total Assets from the begining of last year (Sep13)
to the end of last year (Sep14) was
(5894.155 + 5972.601 + 6075.431 + 6159.737 + 6238.312) / 5 = $6068.0472 Mil.
Total Assets at the begining of last year (Sep13) was $5,894.2 Mil.
Long-Term Debt & Capital Lease Obligation was $2,852.7 Mil.
Total Current Assets was $52.7 Mil.
Total Current Liabilities was $375.9 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

BioMed Realty Trust's current Net Income (TTM) was 209.5. ==> Positive ==> Score 1.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

BioMed Realty Trust's current Cash Flow from Operations (TTM) was 280.5. ==> Positive ==> Score 1.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Sep14)
=209.475/6238.312
=0.0335788

ROA (Last Year)=Net Income/Total Assets (Sep13)
=63.708/5894.155
=0.01080867

BioMed Realty Trust's return on assets of this year was 0.0335788. BioMed Realty Trust's return on assets of last year was 0.01080867. ==> This year is higher. ==> Score 1.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

BioMed Realty Trust's current Net Income (TTM) was 209.5. BioMed Realty Trust's current Cash Flow from Operations (TTM) was 280.5. ==> 280.5 > 209.5 ==> CFROA > ROA ==> Score 1.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Sep15)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Sep14 to Sep15
=2532.169/6303.3042
=0.40172089

Gearing (Last Year: Sep14)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Sep13 to Sep14
=2852.669/6068.0472
=0.47011319

BioMed Realty Trust's gearing of this year was 0.40172089. BioMed Realty Trust's gearing of last year was 0.47011319. ==> This year is lower or equal to last year. ==> Score 1.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Sep15)=Total Current Assets/Total Current Liabilities
=710.082/882.418
=0.80470027

Current Ratio (Last Year: Sep14)=Total Current Assets/Total Current Liabilities
=52.707/375.933
=0.14020317

BioMed Realty Trust's current ratio of this year was 0.80470027. BioMed Realty Trust's current ratio of last year was 0.14020317. ==> This year's current ratio is higher. ==> Score 1.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

BioMed Realty Trust's number of shares in issue this year was 207.802. BioMed Realty Trust's number of shares in issue last year was 199.575. ==> There is larger number of shares in issue this year. ==> Score 0.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=446.558/675.988
=0.66060048

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=455.997/666.946
=0.68370903

BioMed Realty Trust's gross margin of this year was 0.66060048. BioMed Realty Trust's gross margin of last year was 0.68370903. ==> Last year's gross margin is higher ==> Score 0.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Sep14)
=675.988/6238.312
=0.10836072

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Sep13)
=666.946/5894.155
=0.11315379

BioMed Realty Trust's asset turnover of this year was 0.10836072. BioMed Realty Trust's asset turnover of last year was 0.11315379. ==> Last year's asset turnover is higher ==> Score 0.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=1+1+1+1+1+1+0+0+0
=6

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

BioMed Realty Trust has an F-score of 6 indicating the company's financial situation is typical for a stable company.

BioMed Realty Trust  (NYSE:BMR) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


BioMed Realty Trust Piotroski F-Score Related Terms

Thank you for viewing the detailed overview of BioMed Realty Trust's Piotroski F-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


BioMed Realty Trust (BioMed Realty Trust) Business Description

Traded in Other Exchanges
N/A
Address
BioMed Realty Trust Inc, a Maryland corporation was formed on April 30, 2004 and commenced operations on August 11, 2004, after completing its initial public offering. The Company operates as a self-administered and self-managed real estate investment trust focused on acquiring, developing, owning, leasing and managing laboratory and office space for the life science industry mainly through its subsidiary, BioMed Realty, L.P., a Maryland limited partnership Its tenants mainly include biotechnology and pharmaceutical companies, scientific research institutions, government agencies and other entities involved in the life science industry. The Company's properties are generally located in markets with well established reputations as centers for scientific research, including Boston, San Diego, San Francisco, Seattle, Maryland, Pennsylvania and New York/ New Jersey. The Company faces competition from various entities for investment opportunities in properties for life science tenants, including other REITs, such as health care REITs and suburban office property REITs, pension funds, insurance companies, investment funds and companies, partnerships, and developers. The Company's properties are subject to various laws, ordinances and regulations, including regulations relating to common areas.
Executives
Daniel Bradbury director BIOBRIT, LLC, 2223 AVENIDA DE LA PLAYA, SUITE 108, LA JOLLA CA 92037
Brody William R Md Phd director MEDTRONIC, INC, 710 MEDTRONIC PKWY, MS LC310, MINNEAPOLIS MN 55432-5604
Janice L. Sears director 1100 PARK PLACE, SUITE 200, SAN MATEO CA 94403
Alan D Gold director, officer: Chairman, President and CEO 17140 BERNARDO CENTER DRIVE, SUITE 195, SAN DIEGO CA 92128
Gary A Kreitzer director, officer: Exec VP and Assistant Sec 17140 BERNARDO CENTER DRIVE, SUITE 195, SAN DIEGO CA 92128
Margaret Faye Wilson director 12836 LUNADA PLACE, SAN DIEGO CA 92128
Griffin R Kent Jr officer: President and COO 5950 SHERRY LANE, SUITE 700, DALLAS TX 75225
Richard I Gilchrist director 5950 SHERRY LANE, SUITE 700, DALLAS TX 75225